ArticleHaematologica2026

Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone.

Ricardo D Parrondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.